Non-Salesforce shops where the native-architecture advantage disappears (CaptivateIQ, Xactly, Everstage better), buyers wanting standalone independent ICM trajectory, or buyers concerned about the acquisition integration risk.
Salesforce-committed buyers (200-5,000 employees, 50-1,500 reps) already standardizing on Salesforce CPQ and Revenue Cloud, wanting native commission inside the Salesforce data model.
Why we say this
Editorial pulled these weaknesses from Spiff’s product card in our Top 10 Sales Compensation Software for 2026:
- ! Post-Salesforce-acquisition roadmap velocity slowed materially through 2024-2025 (multiple G2 reviews cite slower feature shipping cadence)
- ! Standalone product trajectory uncertain; being absorbed into Revenue Cloud
- ! Spiff branding being phased toward Salesforce; brand discontinuity for customers
- ! Pre-acquisition founder team departures flagged in customer reports
- ! Pricing increasingly bundled with Salesforce contracts; standalone cost transparency reduced
- ! Outside the Salesforce ecosystem the product is materially less compelling
If Spiff is wrong for you, consider these instead
Same Sales Compensation Software category, different best-fit buyer.
Best for
Tech-forward mid-market and upper-mid-market (200-5,000 employees, 50-1,500 reps) wanting modern UX, ASC 606 compliance, and a Xactly alternative without legacy architecture.
See full profile →Best for
Tech-forward mid-market and upper-mid-market sales orgs (200-3,000 employees, 50-1,500 reps) wanting modern ICM UX at more accessible pricing than CaptivateIQ, especially India-HQ SaaS exporters and US SaaS evaluating Indian-engineered platforms.
See full profile →Best for
Insurance carriers, public-sector sales organizations, and APAC mid-market (200-5,000 employees, 100-1,000 reps) wanting proven ICM with stable execution and vertical-aware deployment experience.
See full profile →Related editorial
Last updated 2026-05-23. Editorial verdict based on the published Top 10 Sales Compensation Software for 2026 ranking. Disagree? Tell us.